Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ovintiv Inc. (DE) (OVV) vs Smith & Nephew plc (SNN) Price & Performance

Ovintiv Inc. (DE)Trade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Ovintiv Inc. (DE) vs Smith & Nephew plc — how do they compare? Ovintiv Inc. (DE) trades at $62.88 (market cap $16.99B), while Smith & Nephew plc trades at $27.21 (market cap $11.31B). The key difference: Ovintiv Inc. (DE) is the larger of the two by market cap, and Smith & Nephew plc pays the higher dividend (2.95%). Which is the better fit depends on your goals — on Pluang, investors hold Ovintiv Inc. (DE) for 0 Days and Smith & Nephew plc for 120 Days on average.

OVVSNN
Market Cap
$16.99B$11.31B
Volume
3,019,6781,050,005
Sector
EnergyHealth
52-Week High
$66.97$37.17
52-Week Low
$35.97$26.42
Typical Hold Time
0 Days120 Days
Enterprise Value
$21.32B$14.35B
Dividend Yield
1.95%2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ovintiv Inc. (DE)

No Aura AI signal available yet.

Smith & Nephew plc

SNN trades at $26.96, near its 52-week low, with a bearish technical signal. The company has shown improving fundamentals, with revenue growing from $5.2B in 2022 to $6.16B in 2025 and net income margin expanding to 10.08%. Recent product launches, like the EVOS PELVIC System, highlight innovation, but the stock faces negative sentiment from analyst downgrades and CFO departure news.

The outlook is mixed: strong profitability and cash flow support value, but bearish technicals and cautious analyst consensus (26% buy, 65% hold) suggest limited near-term upside. Key risks include execution challenges and competitive pressures. Investors should weigh solid fundamentals against weak market sentiment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

OVV
100% Buy0% Sell
Avg holding period · 0 Days
SNN

No sentiment data available yet.

About Ovintiv Inc. (DE)

Ovintiv explores for and produces oil and natural gas in North America. Its operations are concentrated in major U.S. and Canadian resource basins.

Read more on OVV →

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →